Quality of Life and Gut Health in Pediatric Patients With Cystic Fibrosis

NARecruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

January 2, 2024

Primary Completion Date

June 1, 2027

Study Completion Date

July 1, 2027

Conditions

Cystic Fibrosis in Children

Interventions

DIETARY_SUPPLEMENT

Multistrain Probiotic

Participants will recieve a multi-strain probiotic daily for 6 months

DIETARY_SUPPLEMENT

Placebo - maltodextrin

Participants will recieve placebo/ maltodextri daily for 6 months

Trial Locations (1)

RECRUITING

Oslo University Hospital, Oslo

All Listed Sponsors

collaborator

Norwegian National Advisory Unit on Rare Disorders, Oslo University Hospital

UNKNOWN

lead

Oslo University Hospital

OTHER

NCT06284577 - Quality of Life and Gut Health in Pediatric Patients With Cystic Fibrosis | Biotech Hunter | Biotech Hunter